Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Pain Medicine (Malden, Mass.)|November 20, 2015
Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced ConstipationCharles E Argoff, Michael J Brennan, Michael Camilleri, et al.
Pain and Therapy|January 29, 2015
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery SystemsJohn F Peppin, Phillip J Albrecht, Charles Argoff, et al.
Pain and Therapy|January 30, 2015
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and ApplicationsJohn F Peppin, Phillip J Albrecht, Charles Argoff, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Recommendations for Neuromodulation in Diabetic Neuropathic PainZachary T Olmsted, Amir Hadanny, Anthony M Marchese, et al.
Pain Medicine (Malden, Mass.)|February 18, 2022
An Algorithmic Approach to the Physical Exam for the Pain Medicine Practitioner: A Review of the Literature with Multidisciplinary ConsensusSayed E Wahezi, Robert Duarte, Chong Kim, et al.
The Clinical Journal of Pain|June 8, 2017
Opioid-sparing Effects of SoluMatrix Indomethacin in a Phase 3 Study in Patients With Acute Postoperative PainChristopher G Gharibo, Charles Argoff, Joseph A Markenson, et al.
The Clinical Journal of Pain|August 21, 2009
Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalitiesMiroslav-Misha Backonja, David Walk, Robert R Edwards, et al.
The Clinical Journal of Pain|August 21, 2009
Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic painDavid Walk, Nalini Sehgal, Tobias Moeller-Bertram, et al.
World Neurosurgery|October 23, 2020
Effect of First-Line Ziconotide Intrathecal Drug Therapy for Neuropathic Pain on Disability, Emotional Well-Being, and Pain CatastrophizingMiriam M Shao, Olga Khazen, Abigail Hellman, et al.
The Journal of Headache and Pain|April 25, 2024
Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based studyCharles Argoff, Steven P Herzog, Ryan M Smith, et al.
Pageof 7